Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820919 · ClinicalTrials.gov registry record · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
A NA study of Alzheimer Disease and Dementia, sponsored by University of Alabama, Tuscaloo.
- Recruiting
- Registry status
- NA
- Development phase
- 456
- Enrollment target
- 3
- Study locations
NCT05820919: Recruiting NA study of Alzheimer Disease and Dementia, sponsored by University of Alabama, Tuscaloo.
NCT05820919 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 456 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820919, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.
- RECRUITING
- Registry status
- NA
- Development phase
- 456 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.
Primary Outcome
Total sleep time (total minutes asleep each nighttime period - 10pm to 7am)
Conditions Studied
Interventions
- BEHAVIORAL LOCK Sleep Program
- OTHER No intervention (control period/baseline data collection)
Study Locations (3)
Colorado
- Vivage/Beecan Corporation - Lakewood
Tennessee
- National HealthCare Corporation - Murfreesboro
Texas
- Caraday Healthcare, LLC - San Marcos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2027-05-29 |
| Phase | NA |
What NCT05820919 shows while recruiting
NCT05820919 is an interventional study that assigns participants to a tested intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (83% lower).
The record links to 4 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which LOCK Sleep Program is the first listed.
NCT05820919 reports a single indexed study location in Colorado, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT05820919 about?
NCT05820919 is a clinical study titled "Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase". This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment...
What is the current status of trial NCT05820919?
This trial is currently recruiting. It is a NA study. The enrollment target is 456 participants. The study started on 2023-09-07. Estimated completion is 2027-05-29.
What conditions does trial NCT05820919 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Sleep Disturbance, Sleep Disorder.
What interventions are being tested in trial NCT05820919?
The interventions under investigation include: LOCK Sleep Program (BEHAVIORAL), No intervention (control period/baseline data collection) (OTHER).
Who is sponsoring clinical trial NCT05820919?
This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05820919 being conducted?
This trial has 3 study locations across Colorado, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05820919's enrollment target sits among peer trials
456 56th of 306 higher than 250 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT06254612 · 456 participants · Phase 2
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
- NCT06457841 · 456 participants · NA
Stress and Resilience
- NCT05541016 · 455 participants · Phase 2
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI